Enveric Biosciences, Inc. (ENVB)
1.41
-0.02
(-1.40%)
USD |
NASDAQ |
Aug 24, 16:00
1.48
+0.07
(+4.96%)
After-Hours: 20:00
Enveric Biosciences Shareholders Equity (Quarterly) : 8.082M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.082M |
| March 31, 2026 | 5.061M |
| December 31, 2025 | 4.178M |
| September 30, 2025 | 3.456M |
| June 30, 2025 | 2.185M |
| March 31, 2025 | 3.918M |
| December 31, 2024 | 1.593M |
| September 30, 2024 | 3.951M |
| June 30, 2024 | 5.406M |
| March 31, 2024 | 6.482M |
| December 31, 2023 | 3.774M |
| September 30, 2023 | 2.436M |
| June 30, 2023 | 4.875M |
| March 31, 2023 | 10.41M |
| December 31, 2022 | 14.67M |
| September 30, 2022 | 22.84M |
| June 30, 2022 | 21.97M |
| March 31, 2022 | 24.44M |
| December 31, 2021 | 22.31M |
| September 30, 2021 | 55.37M |
| June 30, 2021 | 18.82M |
| March 31, 2021 | 18.99M |
| December 31, 2020 | |
| September 30, 2020 | 13.18M |
| June 30, 2020 | 12.88M |
| Date | Value |
|---|---|
| March 31, 2020 | 10.22M |
| December 31, 2019 | 10.62M |
| September 30, 2019 | 13.25M |
| June 30, 2019 | 10.86M |
| March 31, 2019 | 11.16M |
| December 31, 2018 | 10.76M |
| September 30, 2018 | 30.09M |
| June 30, 2018 | 18.30M |
| March 31, 2018 | 19.18M |
| December 31, 2017 | 19.45M |
| September 30, 2017 | 12.20M |
| June 30, 2017 | 13.61M |
| March 31, 2017 | 14.77M |
| December 31, 2016 | 11.66M |
| September 30, 2016 | 4.753M |
| June 30, 2016 | 2.412M |
| March 31, 2016 | -0.8001M |
| December 31, 2015 | 0.2585M |
| September 30, 2015 | 0.9588M |
| June 30, 2015 | 1.118M |
| March 31, 2015 | -0.0064M |
| December 31, 2014 | -0.0039M |
| September 30, 2014 | 0.0068M |
| June 30, 2014 | 0.01M |
| March 31, 2014 | 0.0219M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| LENZ Therapeutics, Inc. | 219.26M |
| Impact BioMedical, Inc. | 10.77M |
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.944M |
| Total Liabilities (Quarterly) | 0.8615M |
| Current Ratio | 10.21 |